Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y, Hanatani S, Kimura Y, Takashio S, Yamamoto E, Kusaka H, Tokitsu T, Rokutanda T, Araki S, Tsujita K, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H. Izumiya Y, et al. Among authors: tokitsu t. Can J Cardiol. 2014 Mar;30(3):338-44. doi: 10.1016/j.cjca.2013.12.010. Epub 2013 Dec 18. Can J Cardiol. 2014. PMID: 24484911
High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction.
Kimura Y, Izumiya Y, Hanatani S, Yamamoto E, Kusaka H, Tokitsu T, Takashio S, Sakamoto K, Tsujita K, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H. Kimura Y, et al. Among authors: tokitsu t. Heart Vessels. 2016 Jan;31(1):52-9. doi: 10.1007/s00380-014-0571-y. Epub 2014 Aug 24. Heart Vessels. 2016. PMID: 25150586
Reactive oxidative metabolites are associated with the severity of heart failure and predict future cardiovascular events in heart failure with preserved left ventricular ejection fraction.
Hirata Y, Yamamoto E, Tokitsu T, Kusaka H, Fujisue K, Kurokawa H, Sugamura K, Maeda H, Tsujita K, Yamamuro M, Kaikita K, Hokimoto S, Sugiyama S, Ogawa H. Hirata Y, et al. Among authors: tokitsu t. Int J Cardiol. 2015 Jan 20;179:305-8. doi: 10.1016/j.ijcard.2014.11.018. Epub 2014 Nov 5. Int J Cardiol. 2015. PMID: 25464471 No abstract available.
The pivotal role of eNOS uncoupling in vascular endothelial dysfunction in patients with heart failure with preserved ejection fraction.
Yamamoto E, Hirata Y, Tokitsu T, Kusaka H, Sakamoto K, Yamamuro M, Kaikita K, Watanabe H, Hokimoto S, Sugiyama S, Maruyama T, Ogawa H. Yamamoto E, et al. Among authors: tokitsu t. Int J Cardiol. 2015;190:335-7. doi: 10.1016/j.ijcard.2015.04.162. Epub 2015 Apr 21. Int J Cardiol. 2015. PMID: 25935623 No abstract available.
Clinical Significance of Brachial-Ankle Pulse Wave Velocity in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction.
Takae M, Yamamoto E, Tokitsu T, Oike F, Nishihara T, Fujisue K, Sueta D, Usuku H, Motozato K, Ito M, Kanazawa H, Araki S, Nakamura T, Arima Y, Takashio S, Suzuki S, Sakamoto K, Soejima H, Yamabe H, Kaikita K, Tsujita K. Takae M, et al. Among authors: tokitsu t. Am J Hypertens. 2019 Jun 11;32(7):657-667. doi: 10.1093/ajh/hpz048. Am J Hypertens. 2019. PMID: 31090886
Prognostic significance of polyvascular disease in heart failure with preserved left ventricular ejection fraction.
Fujisue K, Tokitsu T, Yamamoto E, Sueta D, Takae M, Nishihara T, Oike F, Usuku H, Ito M, Motozato K, Kanazawa H, Araki S, Arima Y, Takashio S, Izumiya Y, Suzuki S, Sakamoto K, Kaikita K, Tsujita K. Fujisue K, et al. Among authors: tokitsu t. Medicine (Baltimore). 2019 Jul;98(28):e15959. doi: 10.1097/MD.0000000000015959. Medicine (Baltimore). 2019. PMID: 31305390 Free PMC article.
29 results